儿童创伤性脑损伤中的静脉血栓栓塞:系统综述与荟萃分析
随机效应模型估计VTE发生率为7%(95%CI 4.4%-10.2%),中心静脉置管患者发生率更高(20%)。风险因素包括损伤严重程度和多模式TBI治疗。研究设计异质性大、VTE监测不一致及以注册研究为主可能低估VTE发生率。结论认为重型TBI患儿VTE风险显著,尤其接受多模式治疗者,亟需标准化监测的前瞻性研究。
要点
- 儿童重型TBI患者VTE合并发生率为7%(95%CI 4.4%-10.2%),基于20项研究n=64,215的荟萃分析。
- 中心静脉置管患者VTE发生率更高,达20%。
- VTE风险因素包括损伤严重程度和多模式TBI治疗。
- 研究设计异质性大、VTE监测不一致及注册研究为主可能低估真实VTE发生率。
- 证据等级为Level III(系统综述与荟萃分析),亟需标准化VTE监测的前瞻性研究。
适用人群与场景
- 纳入标准:同行评议研究,报告儿童中重度TBI患者的VTE发生率、风险因素或药物预防使用情况;荟萃分析纳入20项重型TBI研究(n=64,215,平均年龄14.1岁)。
诊断标准与关键阈值
- 原文未提及具体的VTE诊断标准或评分界值。
处置流程与药物剂量
- 原文未提及具体的药物预防方案、剂量或给药途径。
- 原文提及化学预防(chemoprophylaxis)使用情况被纳入研究筛选标准,但未给出具体推荐方案。
红旗征与不能漏的情况
- 原文未提及具体的红旗征或需立刻处理的情况。
研究设计与关键结果
- 主要终点:VTE发生率为7%(95%CI 4.4%-10.2%)。
- 亚组:中心静脉置管患者VTE发生率为20%。
- 风险因素:损伤严重程度和多模式TBI治疗(叙述性合成)。
- 异质性:研究设计异质性限制结果解释;VTE监测不一致及注册研究为主可能低估VTE发生率。
证据类型、等级与局限
- 证据类型:系统综述与荟萃分析,证据等级Level III。
- 局限:研究设计异质性大;VTE监测不一致;以注册研究为主可能低估VTE发生率;风险因素和化学预防证据为叙述性合成。
对床旁实践的改变
- 提示儿童重型TBI患者(尤其接受多模式治疗或中心静脉置管者)VTE风险不可忽视,床旁应提高对VTE的警惕。
- 原文未提供具体的筛查或预防方案推荐,不能据此改变现有预防策略。
- 需注意现有证据以注册研究为主且监测不一致,7%的发生率可能为低估而非精确阈值。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Venous thromboembolism (VTE) is a serious under-recognized complication in pediatric patients with traumatic brain injury (TBI). Understanding VTE frequency and risk factors is fundamental for prevention. The objective of this systematic review was to determine VTE frequency and risk factors in pediatric patients with TBI.
METHODS: PubMed, Embase, Scopus, Web of Science, Google Scholar, The Cochrane Library, ClinicalTrials.gov, and WorldCat were systematically searched through June 2025. Peer-reviewed studies that reported on VTE frequency, risk factors, or chemoprophylaxis use in pediatric patients with moderate or severe TBI were eligible for inclusion. Two reviewers independently screened studies and assessed risk of bias. Data were extracted by one reviewer and verified by another. VTE frequency was estimated using a random-effects model; subgroup analyses and mixed-effects meta-regression explored effect modifiers. Evidence on risk factors and chemoprophylaxis was synthesized narratively. The protocol was registered in PROSPERO (CRD42024570459).
RESULTS: Twenty-nine studies were included; 20 studies in patients with severe TBI (n=64,215, mean age 14.1 y) were pooled for meta-analysis. VTE frequency was 7% (95% CI: 4.4%-10.2%). Frequency was higher in patients with central venous lines (20%). Risk factors included injury severity and multimodality TBI treatment. Heterogeneity in study designs limits the interpretability of the results. Inconsistent VTE surveillance and the predominance of registry-based studies may have led to underestimation of VTE frequency.
CONCLUSIONS: Pediatric patients with severe TBI seem to be at substantial risk of VTE, particularly when they undergo multimodality treatment. Prospective studies with standardized VTE surveillance are urgently needed.
LEVEL OF EVIDENCE: Level III, systematic review and meta-analysis.
参考来源
- Hoffmann I, Chit M, Mayeden S, et al. Venous thromboembolism in pediatric traumatic brain injury: A systematic review and meta-analysis. J Trauma Acute Care Surg. 2026. PMID: 42743555. doi:10.1097/TA.0000000000005170
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。